Jun Nakata

10PUBLICATIONS
42CO-AUTHORS
Tumour immunologyHaematological tumoursMedical bacteriologyMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2026
Twenty-year persistence of WT1-specific cytotoxic T lymphocytes in peritumoral brain tissue by peptide vaccine therapy: Transcriptomic evidence for resident memory T-cell induction.

|Jun 17, 2026
WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase 2 study.

|Aug 16, 2024
Identification of causative fungus from sterile abscess using metagenomics followed by in situ hybridization.

Hiroya Oki, Ryotaro Niwa, Somboonthum Pranee

|Jan 21, 2023
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1.

Yusuke Oji, Naoki Kagawa, Hideyuki Arita

|Feb 16, 2022
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain.

Kana Hasegawa, Shunya Ikeda, Moto Yaga

|Jul 02, 2021
Imaging Assessment of Tumor Response in the Era of Immunotherapy.

Jun Nakata, Kayako Isohashi, Yoshihiro Oka

Pageof 2

Frequent Collaborators

2 joint publications

Akihiro Tsuboi

2 joint publications

Sumiyuki Nishida

2 joint publications

Yasushi Shintani

1 joint publications

Kayako Isohashi